Study Stopped
IRB closure, slow accrual
Radiation Therapy on Pelvic Floor Disorders in Women
RadPFD
Exploring the Impact of Radiation Therapy on Pelvic Floor Disorders in Women Treated for Colorectal Cancer (RadPFD)
3 other identifiers
observational
49
1 country
1
Brief Summary
Investigators propose a retrospective cohort study to examine the impact of radiation therapy on the global pelvic floor function of women who have completed the immediate surveillance period for colorectal cancer
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2020
CompletedFirst Posted
Study publicly available on registry
November 10, 2020
CompletedStudy Start
First participant enrolled
May 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 14, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 14, 2022
CompletedNovember 7, 2023
November 1, 2023
11 months
November 5, 2020
November 1, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Urinary Dysfunction - International Consultation on Incontinence Questionnaire - Female Lower Urinary Tract Symptoms (ICIQ-FLUTS)
The ICIQ-FLUTS is a 12-item validated, self-administered questionnaire that is derived from the Bristol Female Lower Urinary Tract Symptoms (BF-LUTS) questionnaire and designed for use in women and to assess urinary symptoms and effects on quality of life. There are 3 subscales within this instrument to assess incontinence, voiding and filling. Investigators will specifically use the incontinence subscale as the primary outcome. The instrument is based on 5 questions, with possible answers on a 5-point scale (ranging from "never" to "all of the time"). Scoring is 0-48 with higher scores equaling to a greater bother with urinary dysfunction in participants.
Up to 4 months
Secondary Outcomes (5)
PROMIS® Brief Profile Sexual Function and Satisfaction (Female)
Up to 4 months
Bowel Dysfunction - Modified Manchester Health Questionnaire
Up to 4 months
PROMIS® Brief Profile Sexual Function and Satisfaction- Male or Female Partners
Up to 4 months
Dyadic Adjustment Scale-Short Form (DAS-7) Questionnaire - Couple Relationship
Up to 4 months
Short Form-12 Questionnaire - General Health and Well Being
Up to 4 months
Study Arms (2)
Surgery Only Group
Participants will complete a questionnaires regarding demographics and medical history on a secured REDCap link.
Surgery and Radiation Therapy Group
Participants will complete a questionnaires regarding demographics and medical history on a secured REDCap link.
Interventions
Once consent is obtained, the participants will be routed to a REDCap secure link. Participants will complete a questionnaires regarding demographics and medical history. Participants will also complete validated questionnaires regarding their lower urinary and bowel tract function and sexual health- International Consultation on Incontinence Questionnaire Female Lower Urinary Tract Symptoms (ICIQ-FLUTS), Modified Manchester Health Questionnaire (MMHQ), PROMIS® v2.0 Brief Profile Sexual Function and Satisfaction (Female) and SF-12 ® .
Eligibility Criteria
Female survivors of colorectal cancer and their partners.
You may qualify if:
- Living, female patients.
- Age 18 or older with a diagnosis of colorectal cancer (current or past, regardless of Stage)-confirmed by pathology report - made between the years of 2015 and 2018.
- History of treatment for colorectal cancer in the Wake Forest Baptist Health System.
- Sexual partners of the above participants (subjects can participate even if they are not sexually active or if no sexual partner is available).
- English speaking.
You may not qualify if:
- No internet access.
- Non-English speakers (validated instruments are only available in English).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Wake Forest Baptist Health
Winston-Salem, North Carolina, 27103, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Candace Parker-Autry, MD
Wake Forest University Health Sciences
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 5, 2020
First Posted
November 10, 2020
Study Start
May 5, 2021
Primary Completion
April 14, 2022
Study Completion
April 14, 2022
Last Updated
November 7, 2023
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share